Brexpiprazole Overview and Dosage
6 Questions
100 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the brand name of brexpiprazole?

Rexulti

What conditions is Rexulti (brexpiprazole) prescribed for?

Schizophrenia (ages 13 to 17 and in adults), treatment-resistant depression (adjunct)

What is the pharmacological class of brexpiprazole?

Dopamine partial agonist

What is the usual dosage of Rexulti for schizophrenia in ages 13 to 17 and adults?

<p>2-4 mg once daily</p> Signup and view all the answers

What are some important considerations regarding Rexulti (brexpiprazole) when breastfeeding?

<p>Discontinue drug or bottle feed</p> Signup and view all the answers

Which of the following drugs are partial agonists of D2? (Select all that apply)

<p>Rexulti</p> Signup and view all the answers

Study Notes

Drug Overview

  • Brexpiprazole is marketed under the brand name Rexulti.
  • Prescribed for schizophrenia in patients aged 13 to 17 and adults, and as an adjunct treatment for treatment-resistant depression.

Pharmacological Classification

  • Classified as a dopamine partial agonist.
  • Also recognized as a dopamine-serotonin partial agonist and a stabilizer.
  • Categorized as an atypical antipsychotic, and sometimes deemed a second-generation antipsychotic.
  • Possesses potential mood stabilizing properties.

Dosage Information

  • Recommended dosage for schizophrenia: 2-4 mg taken once daily for individuals aged 13 and older.
  • Suggested starting dosage for depression: 2 mg taken once daily.

Important Considerations

  • Approved as an adjunctive treatment for depression, often in combination with SSRIs or SNRIs.
  • Contraindicated in breastfeeding; either discontinue the drug or opt for bottle feeding.
  • Notable side effects include akathisia and restlessness, both of which are dose-dependent, along with potential anxiety.

Other Relevant Drugs

  • Three drugs exhibiting partial agonism at D2 receptors include Abilify, Rexulti, and Vraylar.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

This quiz covers the important aspects of Brexpiprazole, including its pharmacological classification, recommended dosages for schizophrenia and depression, and key considerations for its use. Test your knowledge on this atypical antipsychotic, its mechanisms, and its side effects.

Use Quizgecko on...
Browser
Browser